Participants with neurological disorders will be recruited to complete sessions of virtual reality (VR) immersion. VR has been shown to have therapeutic benefit in certain patient populations and requires further clinical study to determine the extent to which VR can be used to rehabilitate and reduce symptom burden. This study seeks to pilot newly developed VR methods and collect preliminary data in order to support research grants and inform larger clinical trials. Additionally, this proposed study will explore the tolerability and preliminary efficacy of Virtual Reality (VR), specifically to determine whether VR can acutely reduce the severity of symptom burden caused by neurological disorders.
18-79 years of age Has been diagnosed by a clinician as having MS Able to commit to the designated period of testing Able to understand the informed consent process and provide consent to participate in the study Capacity to complete study procedures as determined by screening personnel A Brief Pain Inventory interference score of at least 3 or more. SDMT Z-Score > -3.0 WRAT4 Standard Score > or = 85
Exclusion Criteria:
Visual, auditory, and motor deficits that would prevent full ability to understand study Visual, auditory, and motor deficits that would prevent full ability to operate VR equipment Uncontrolled epilepsy Current diagnosis of vertigo Uncontrolled mood disorders History of Psychosis or Schizophrenia Expanded Disability Status Scale (EDSS) Score greater than 6.5 Unable to tolerate or manipulate VR treatment procedures (as evidenced by VR capability assessment)
